It isn’t easy having cancer. But like gardening in a harsh climate, survival and growth come from strategies, adaptation, and ...

The U.S. Food and Drug Administration (FDA) has granted full approval to Vitrakvi (larotrectinib) for the treatment of adult ...

The first patient has been dosed in a phase 1 clinical trial of CT-95 among patients with mesothelin-expressing solid tumors.

Dr. Lillian L. Siu discussed potential risk factors and treatment strategies associated for patients with head and neck ...

Extraordinary Healer® Award was presented during the 50th Annual Oncology Nursing Society Congress, recognizing oncology nursing professionals' dedication and impact.

Because the five-year relative survival rate for people with esophageal cancer is approximately 22%, this makes early ...

Dr. Sheri Yolanda Prentiss discusses lymphedema as a result of cancer treatment and shares resources that exist for patients ...

After living with lymphoma for 15 and a half years, my doctor has suggested reducing the dose of my medication and possibly ...

A test to identify higher risk of developing urinary side effects after radiation in patients with prostate cancer was ...

Cancer is a distraction and not always a bad one. We do learn perspective. There are some good things we can take away in ...

The American Heart Association has released a statement detailing cardiometabolic considerations for survivors of childhood ...

The FDA granted a positive review for an acute myeloid leukemia drug trial, with initial dosing expected in 2025.